Women's health: Selected topics

Primary Care - Clinics in Office Practice

Volumn 37, Issue 2, 2010, Pages 367-387

  Zoorob, Roger J ^a   Sidani, Mohamad ^a   Williams, Jamila ^a   Grief, Samuel N ^b  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Alternative medicine; Complementary medicine; Women's health

Indexed keywords

ALPHA TOCOPHEROL; BENDECTIN; BENEDICTIN; CALCIUM; CALCIUM CARBONATE; CIMICIFUGA RACEMOSA EXTRACT; FISH OIL; GABAPENTIN; GINGER EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IBUPROFEN; IPRIFLAVONE; IPROSTEN; ISOFLAVONE; MAGNESIUM; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; ORAL CONTRACEPTIVE AGENT; OSTOVONE; PHYTOESTROGEN; PHYTOMENADIONE; PLACEBO; POLLEN EXTRACT; PRIMROSE OIL; PYRIDOXINE; THIAMINE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN K GROUP;

ACUPRESSURE; ACUPUNCTURE; ALTERNATIVE MEDICINE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSMENORRHEA; EMBRYO TRANSFER; EVIDENCE BASED MEDICINE; EXERCISE; FERTILIZATION IN VITRO; FLUID THERAPY; HERBAL MEDICINE; HUMAN; HYPEREMESIS GRAVIDARUM; HYPERTHERMIC THERAPY; HYPNOSIS; INFERTILITY; LYMPHOCYTOPENIA; MENOPAUSAL SYNDROME; MENOPAUSE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; ORTHOPEDIC MANIPULATION; OSTEOPOROSIS; PREMENSTRUAL SYNDROME; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; TAI CHI; TEA; UNSPECIFIED SIDE EFFECT; WOMEN'S HEALTH;

COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; HYPEREMESIS GRAVIDARUM; INFERTILITY, FEMALE; MENOPAUSE; MENSTRUATION DISTURBANCES; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOTHERAPY; PLANT PREPARATIONS; PREGNANCY; PREMENSTRUAL SYNDROME;

EID: 77952892736     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2010.02.011     Document Type: Review

References (147)

1. Hollenberg D., Zakus D., Cook T., et al. Re-positioning the role of traditional, complementary and alternative medicine as essential health knowledge in global health: do they still have a role to play?. World Health Popul 2009, 10(4):62-75.
2. Fugh-Berman A., Kronenberg F. Complementary and alternative medicine (CAM) in reproductive-age women: a review of randomized controlled trials. Reprod Toxicol 2003, 17(2):137-152.
3. Domoney C.L., Vashisht A., Studd J.W. Premenstrual syndrome and the use of alternative therapies. Ann N Y Acad Sci 2003, 997:330-340.
4. Lefebvre G., Pinsonneault O., Antao V., et al. Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can 2005, 27(12):1117-1146.
5. French L. Dysmenorrhea. Am Fam Physician 2005, 71(2):285-291.
6. Tseng Y.F., Chen C.H., Yang Y.H. Rose tea for relief of primary dysmenorrhea in adolescents: a randomized controlled trial in Taiwan. J Midwifery Womens Health 2005, 50(5):e51-e57.
7. Proctor M.L., Murphy P.A., Pattison H.M., et al. Behavioural interventions for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2007, (3). CD002248.
8. Zhu X., Proctor M., Bensoussan A., et al. Chinese herbal medicine for primary dysmenorrhoea. Cochrane Database Syst Rev 2008, (2). CD005288.
9. Pirotta M. Commentary on the Cochrane Review of Chinese herbal medicine for dysmenorrhea. Explore (NY) 2008, 4(6):389-391.
10. Kennedy S., Jin X., Yu H., et al. Randomized controlled trial assessing a traditional Chinese medicine remedy in the treatment of primary dysmenorrhea. Fertil Steril 2006, 86(3):762-764.
11. Gokhale L.B. Curative treatment of primary (spasmodic) dysmenorrhea. Indian J Med Res 1996, 103:227-231.
12. Dennehy C.E. The use of herbs and dietary supplements in gynecology: an evidence-based review. J Midwifery Womens Health 2006, 51:402-409.
13. Proctor M., Murphy P.A. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2001, (2). CD002124.
14. Saldeen P., Saldeen T. Women and omega-3 fatty acids. Obstet Gynecol Surv 2004, 59:722-730.
15. Blanche Butler E., McKnight E. Vitamin E in the treatment of primary dysmenorrhea. Lancet 1955, 268:844-847.
16. Ziaei S., Faghihzadeh S., Sohrabvand F., et al. A randomized placebo-controlled trial to determine the efficacy of vitamin E in treatment of primary dysmenorrhea. Br J Obstet Gynaecol 2001, 108:1181-1183.
17. Ziaei S., Zakeri M., Kazemnejad A. A randomized controlled trial of vitamin E in the treatment of primary dysmenorrhea. BJOG 2005, 112:466-469.
18. Yang H., Liu C.Z., Chen X., et al. Systematic review of clinical trials of acupuncture-related therapies for primary dysmenorrhea. Acta Obstet Gynecol Scand 2008, 87(11):1114-1122.
19. Sanfilippo J., Erb T. Evaluation and management of dysmenorrhea in adolescents. Clin Obstet Gynecol 2008, 51(2):257-267.
20. White A.R. A review of controlled trials of acupuncture for women's reproductive health care. J Fam Plann Reprod Health Care 2003, 29(4):233-236.
21. Taylor D., Miaskowski C., Kohn J. A randomized clinical trial of the effectiveness of an acupressure device (relief brief) for managing symptoms of dysmenorrhea. J Altern Complement Med 2002, 8:357-370.
22. Witt C., Reinhold T., Brinkhaus B., et al. Acupuncture in patients with dysmenorrheal: a randomized study on clinical effectiveness and cost-effectiveness in usual care. Am J Obstet Gynecol 2008, 198:166.e1-166.e8.
23. Hondras M.A., Long C.R., Brennan P.C. Spinal manipulative therapy versus a low force mimic maneuver for women with primary dysmenorrhea: a randomized, observer-blinded, clinical trial. Pain 1999, 81:105-114.
24. Kokjohn K., Schmid D.M., Triano J.J., et al. The effect of spinal manipulation on pain and prostaglandin levels in women with primary dysmenorrhea. J Manipulative Physiol Ther 1992, 15(5):279-285.
25. Chou P.B., Morse C.A. Understanding premenstrual syndrome from a Chinese medicine perspective. J Altern Complement Med 2005, 11(2):355-361.
26. Girman A., Lee R., Kligler B. An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol 2003, 188(Suppl 5):S56-S65.
27. Busse J.W., Montori V.M., Krasnik C., et al. Psychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trials. Psychother Psychosom 2009, 78(1):6-15.
28. Dog T.L., Micozzi M.S. Women's health in complementary and integrative medicine: a clinical guide 2005, Churchill Livingstone, Edinburgh.
29. Treloar S.A., Heath A.C., Martin N.G. Genetic and environmental influences on premenstrual symptoms in an Australian twin sample. Psychol Med 2002, 32:25-38.
30. Dickerson L., Mazyck P., Hunter M. Premenstrual syndrome. Am Fam Physician 2003, 67(8):1743-1752.
31. Prior J.C., Vigna Y., Sciarretta D., et al. Conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-month trial. Fertil Steril 1987, 47:402-408.
32. Steege J.F., Blumenthal J.A. The effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study. J Psychosom Res 1993, 37(2):127-133.
33. Stevinson C., Ernst E. Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials. Am J Obstet Gynecol 2001, 185:227-235.
34. London R.S., Sundaram G.S., Murphy L., et al. The effect of alpha-tocopherol on premenstrual symptomatology: a double-blind study. J Am Coll Nutr 1983, 2:115-122.
35. London R.S., Sundaram G., Manimekalai S., et al. The effect of alpha-tocopherol on premenstrual symptomatology: a double-blind study. II. Endocrine correlates. J Am Coll Nutr 1984, 3:351-356.
36. London R.S., Murphy L., Kitlowski K.E., et al. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome. J Reprod Med 1987, 32(6):400-404.
37. Thys-Jacobs S., Ceccarelli S., Bierman A., et al. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med 1989, 4:183-189.
38. Thys-Jacobs S., Starkey P., Bernstein D., et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 1998, 179:444-452.
39. Roemheld-Hamm B. Chasteberry. Am Fam Physician 2005, 72:821-824.
40. Turner S., Mills S. A double-blind clinical trial on a herbal remedy for premenstrual syndrome: a case study. Complement Ther Med 1993, 1:73-77.
41. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. Br Med J 2001, 322:134-137.
42. Lauritzen C., Reuter H.D., Repges R., et al. Treatment of premenstrual tension syndrome with Vitex agnus castus. Controlled, double-blind study versus pyridoxin. Phytomedicine 1997, 4:183-190.
43. Atmaca M., Kumru S., Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol 2003, 18:191-195.
44. Jing Z., Yang X., Ismail K.M., et al. Chinese herbal medicine for premenstrual syndrome. Cochrane Database Syst Rev 2009, (1). CD006414.
45. Gerhardsen G., Hansen A.V., Killi M., et al. The efficacy of femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study. Adv Ther 2008, 25:595-607.
46. Hicks S.M., Walker A.F., Gallagher J., et al. The significance of " nonsignificance" in randomized controlled studies: a discussion inspired by a double-blinded study on St. John's wort (Hypericum perforatum L.) for premenstrual symptoms. J Altern Complement Med 2004, 10(6):925-932.
47. Quinlan J., Hill A. Nausea and vomiting of pregnancy. Am Fam Physician 2003, 68(1):121-128.
48. Bottomley C., Bourne T. Management strategies for hyperemesis. Best Pract Res Clin Obstet Gynaecol 2009, 23:549-564.
49. Smith J.A., Refuerzo J.S., Ramin S.M. Treatment of nausea and vomiting of pregnancy (hyperemesis gravidarum and morning sickness) Updated October 5, 2009. Available at:, Accessed December 15, 2009. http://www.uptodate.com/online/content/topic.do?topicKey=pregcomp/35410&selectedTitle=2%7E37&source=search_result.
50. Puangsricharern A., Mahasukhon S. Effectiveness of auricular acupressure in the treatment of nausea and vomiting in early pregnancy. J Med Assoc Thai 2008, 91:1633-1638.
51. Stainton M.C., Neff E.J. The efficacy of SeaBands for the control of nausea and vomiting in pregnancy. Health Care Women Int 1994, 15:563-575.
52. Jewell D., Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev 2003, (4). CD000145.
53. Helmreich R.J., Shiao S.Y., Dune L.S. Meta-analysis of acustimulation effects on nausea and vomiting in pregnant women. Explore (NY) 2007, 3:94.
54. Heazell A., Thorne J. Acupressure for the in-patient treatment of nausea and vomiting in early pregnancy: a randomized control trial. Am J Obstet Gynecol 2006, 194:815-820.
55. Neri I., Allais G., Schiapparelli P. Acupuncture versus pharmacological approach to reduce hyperemesis gravidarum discomfort. Minerva Ginecol 2005, 57:471-475.
56. Smith C., Crowther C., Beilby J. Pregnancy outcome following women's participation in a randomised controlled trial of acupuncture to treat nausea and vomiting in early pregnancy. Complement Ther Med 2002, 10:78-83.
57. White B. Ginger: an overview. Am Fam Physician 2007, 75:1689-1691.
58. Portnoi G., Chng L.A., Karimi-Tabesh L., et al. Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. Am J Obstet Gynecol 2003, 189:1374-1377.
59. Borrelli F., Capasso R., Aviello G., et al. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol 2005, 105:849-856.
60. Fischer-Rasmussen W., Kjaer S.K., Dahl C., et al. Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol 1991, 38:19-24.
61. Ozgoli F., Goli M., Simbar M. Effects of ginger on pregnancy, nausea, and vomiting. J Altern Complement Med 2009, 15:243-246.
62. Sahakian V., Rouse D., Sipes S., et al. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study. Obstet Gynecol 1991, 78:33-36.
63. Vutyavanich T., Wongtra-ngan S., Ruangsri R. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 1995, 173:881-884.
64. Tan P.C., Yow C.M., Omar S.Z. A placebo-controlled trial of oral pyridoxine in hyperemesis gravidarum. Gynecol Obstet Invest 2009, 67:151-157.
65. Sweet M.G., Sweet J., Jeremiah M., et al. Diagnosis and treatment of osteoporosis. Am Fam Physician 2009, 79(3):193-200.
66. U.S.Department of Health and Human Services Bone health and osteoporosis: a report of the surgeon general 2004 Available at:, Accessed March 20, 2010. http://www.surgeongeneral.gov/library/bonehealth/content.html.
67. National Institutes of Health Consensus conference: osteoporosis. JAMA 1984, 52:799-802.
68. Siris E.S., Miller P.D., Barrett-Connor E., et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the national osteoporosis risk assessment. JAMA 2001, 286:2815-2822.
69. Boonen S., Vanderschueren D., Haentjens P., et al. Calcium and vitamin D in the prevention and treatment of osteoporosis-a clinical update. J Intern Med 2006, 259(6):539-552.
70. American College of Obstetricians and Gynecologists (ACOG) Osteoporosis 2004, American College of Obstetricians and Gynecologists (ACOG), Washington, DC, 14 p. (ACOG practice bulletin; no. 50).
71. Clinician's guide to prevention and treatment of osteoporosis 2008, National Osteoporosis Foundation, Washington, DC.
72. Tang B.M., Eslick G.D., Nowson C., et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007, 370:657-666.
73. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride 1997, National Academy Press, Washington, DC, Institute of Medicine Available at:, Accessed December 1, 2009. http://www.nap.edu/openbook.php%3Frecord_id%3D5776%26page%3D1.
74. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
75. Booth S.L. Roles for vitamin K beyond coagulation. Annu Rev Nutr 2009, 29:89-110.
76. Braam L.A., Knapen M.H., Geusens P., et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 2003, 73:21-26.
77. Cheung A.M., Tile L., Lee Y., et al. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO Trial): a randomized controlled trial. PLoS Med 2008, 5:1461-1471.
78. Bolton-Smith C., McMurdo M.E., Paterson C.R., et al. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J Bone Miner Res 2007, 22:509-519.
79. Booth S.L., Dallal G., Shea M.K., et al. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 2008, 93:1217-1223.
80. Poulsen R.C., Kruger M.C. Soy phytoestrogens: impact on postmenopausal bone loss and mechanism of action. Nutr Rev 2008, 66(7):359-374.
81. Michelfelder A.J. Soy: a complete source of protein. Am Fam Physician 2009, 79:43-47.
82. Ma D.F., Qin L.Q., Wang P.Y., et al. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr 2008, 27:57-64.
83. Messina M., McCaskill-Stevens W., Lampe J.W. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst 2006, 98(18):1275-1284.
84. Soung D.Y., Patade A., Khalil D.A., et al. Soy protein supplementation does not cause lymphocytopenia in postmenopausal women. Nutr J 2006, 5:12-17.
85. Alexandersen P., Toussaint A., Christiansen C., et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA 2001, 285:1482-1488.
86. Gennari C., Adami S., Agnusdei D., et al. Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass. Calcif Tissue Int 1997, 61:S19-S22.
87. Adami S., Buffalino L., Cervetti R., et al. Ipriflavone prevents radial bone loss in postmenopausal with low bone mass over 2 years. Osteoporos Int 1997, 7:119-125.
88. Gennari C., Agnusdei D., Crepaldi G., et al. Effect of ipriflavone-a synthetic derivative of natural isoflavones-on bone mass loss in the early years after menopause. Menopause 1998, 5:9-15.
89. Agnusdei D., Zacchei F., Bigazzi S., et al. Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis. Drugs Exp Clin Res 1989, 15:97-104.
90. Ohta H., Komukai S., Makita K., et al. Effects of 1-year ipriflavone treatment on lumbar bone mineral density and bone metabolic markers in postmenopausal women with low bone mass. Horm Res 1999, 51:178-183.
91. Agnusdei D., Bufalino L. Efficacy of ipriflavone in established osteoporosis and long-term safety. Calcif Tissue Int 1997, 61:23-27.
92. Agnusdei D., Crepaldi G., Isaia G., et al. A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss. Calcif Tissue Int 1997, 61:142-147.
93. Moscarini M., Patacchiola F., Spacca G., et al. New perspectives in the treatment of postmenopausal osteoporosis: ipriflavone. Gynecol Endocrinol 1994, 8:203-207.
94. Passeri M., Biondi M., Costi D., et al. Effect of ipriflavone on bone mass in elderly osteoporotic women. Bone Miner 1992, 19(Suppl 1):S57-S62.
95. Bonde M., Qvist P., Fledelius C., et al. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995, 80:864-868.
96. Lee M.S., Pittler M.H., Shin B.C., et al. Tai chi for osteoporosis: a systematic review. Osteoporos Int 2008, 19(2):139-146.
97. Bonaiuti D., Shea B., Iovine R., et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev 2002, (2). CD000333.
98. de Jong Z., Munneke M., Lems W.F., et al. Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial. Arthritis Rheum 2004, 50:1066-1076.
99. Bergström I., Landgren B., Brinck J., et al. Physical training preserves bone mineral density in postmenopausal women with forearm fractures and low bone mineral density. Osteoporos Int 2008, 19:177-183.
100. Englund U., Littbrand H., Sondell A., et al. A 1-year combined weight-bearing training program is beneficial for bone mineral density and neuromuscular function in older women. Osteoporos Int 2005, 16:1117-1123.
101. Gusi N., Raimundo A., Leal A. Low-frequency vibratory exercise reduces the risk of bone fracture more than walking: a randomized controlled trial. BMC Musculoskelet Disord 2006, 7:92-99.
102. Verschueren S.M., Roelants M., Delecluse C., et al. Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women: a randomized controlled pilot study. J Bone Miner Res 2004, 19:352-359.
103. Fracture prevention treatments for postmenopausal women with osteoporosis (AHRQ 2008), Clinician Summary Guide published 11 June 2008. Available at:, Accessed December 23, 2009. http://effectivehealthcare.ahrq.gov/healthInfo.cfm%3Finfotype=sg&DocID=95&ProcessID=8.
104. Oncken C., Prestwood K., Kleppinger A., et al. Impact of smoking cessation on bone mineral density in postmenopausal women. J Womens Health (Larchmt) 2006, 15:1141-1150.
105. Devine A., Hodgson J.M., Dick I.M., et al. Tea drinking is associated with benefits on bone density in older women. Am J Clin Nutr 2007, 86:1243-1247.
106. Mosher W.D., Bachrach C.A. Understanding U.S. fertility: continuity and change in the National Survey of Family Growth, 1988-1995. Fam Plann Perspect 1996, 28(1):4-12.
107. Jose-Miller A.B., Boyden J.W., Frey K.A. Infertility. Am Fam Physician 2007, 75(6):849-856.
108. Boivin J., Schmidt L. Use of complementary and alternative medicines associated with a 30% lower ongoing pregnancy/live birth rate during 12 months of fertility treatment. Humanit Rep 2009, 24(7):1626-1631.
109. Collins J.A., Van Steirteghem A. Overall prognosis with current treatment of infertility. Hum Reprod Update 2004, 10(4):309-316.
110. Geraldine M., Herman D.S., Venkatesh T. Lead poisoning as a result of infertility treatment using herbal remedies. Arch Gynecol Obstet 2007, 275(4):279-281.
111. Coulson C., Jenkins J. Complementary and alternative medicine utilisation in NHS and private clinic settings: a United Kingdom survey of 400 infertility patients. J Exp Clin Assist Reprod 2005, 2(1):5.
112. Manheimer E., Zhang G., Udoff L., et al. Effects of acupuncture on rates of pregnancy and live birth among women undergoing in vitro fertilisation: systematic review and meta-analysis. BMJ 2008, 336(7643):545-549.
113. Song J.J., Yan M.E., Wu X.K., et al. Progress of integrative Chinese and Western medicine in treating polycystic ovarian syndrome caused infertility. Chin J Integr Med 2006, 12(4):312-316.
114. El-Toukhy T., Sunkara S.K., Khairy M., et al. A systematic review and meta-analysis of acupuncture in in vitro fertilisation. BJOG 2008, 115(10):1203-1213.
115. ® for female infertility. randomized, placebo-controlled, clinical Double-Blind Study. Research in complementary medicine]. Forsch Komplementarmed 1998, 5(6):272-278. [in German].
116. Bergmann J., Luft B., Boehmann S., et al. Forsch Komplementarmed Klass Naturheilkd 2000, 7(4):190-199. [in German].
117. Westphal L.M., Polan M.L., Trant A.S., et al. A nutritional supplement for improving fertility in women: a pilot study. J Reprod Med 2004, 49(4):289-293.
118. Wilson C.W. Letter: vitamin C and fertility. Lancet 1973, 2(7833):859-860.
119. Henmi H., Endo T., Kitajima Y., et al. Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. Fertil Steril 2003, 80(2):459-461.
120. Igarashi M. Augmentative effect of ascorbic acid upon induction of human ovulation in clomiphene-ineffective anovulatory women. Int J Fertil 1977, 22(3):168-173.
121. Coyle M., Smith C. A survey comparing TCM diagnosis, health status and medical diagnosis in women undergoing assisted reproduction. Acupunct Med 2005, 23(2):62-69.
122. Xu X., Yin H., Tang D., et al. Application of traditional Chinese medicine in the treatment of infertility. Hum Fertil (Camb) 2003, 6(4):161-168.
123. Shaikh B.T., Hatcher J. Complementary and alternative medicine in Pakistan: prospects and limitations. Evid Based Complement Alternat Med 2005, 2(2):139-142.
124. Azaizeh H., Saad B., Cooper E., et al. Traditional Arabic and Islamic medicine, a re-emerging health aid. Evid Based Complement Alternat Med 2008, [Epub ahead of print].
125. NIH State-of-the-Science Panel. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005, 142(12 Pt 1):1003-1013.
126. Carroll D.G. Nonhormonal therapies for hot flashes in menopause. Am Fam Physician 2006, 73(3):457-464.
127. Kupferer E.M., Dormire S.L., Becker H. Complementary and alternative medicine use for vasomotor symptoms among women who have discontinued hormone therapy. J Obstet Gynecol Neonatal Nurs 2009, 38(1):50-59.
128. American College of Obstetricians and Gynecologists Women's Health Care Physicians. Vasomotor symptoms. Obstet Gynecol 2004, 104(Suppl 4):106S-117S.
129. North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004, 11(1):11-33.
130. Cobin R.H., Futterweit W., Ginzburg S.B., et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocr Pract 2006, 12(3):315-337.
131. Pockaj B.A., Gallagher J.G., Loprinzi C.L., et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 2006, 24(18):2836-2841.
132. Tice J.A., Ettinger B., Ensrud K., et al. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA 2003, 290(2):207-214.
133. Hooper L., Ryder J.J., Kurzer M.S., et al. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update 2009, 15(4):423-440.
134. Jacobs A., Wegewitz U., Sommerfeld C., et al. Efficacy of isoflavones in relieving vasomotor menopausal symptoms - a systematic review. Mol Nutr Food Res 2009, 53(9):1084-1097.
135. Ziaei S., Kazemnejad A., Zareai M. The effect of vitamin E on hot flashes in menopausal women. Gynecol Obstet Invest 2007, 64(4):204-207.
136. Biglia N., Sgandurra P., Peano E., et al. Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E. Climacteric 2009, 12(4):310-318.
137. Vickers A., Zollman C. ABC of complementary medicine. Acupuncture. BMJ 1999, 319(7215):973-976.
138. Borud E.K., Alraek T., White A., et al. The acupuncture on hot flushes among menopausal women (ACUFLASH) study, a randomized controlled trial. Menopause 2009, 16(3):484-493.
139. Kim K.H., Kang K.W., Kim D.I., et al. Effects of acupuncture on hot flashes in perimenopausal and postmenopausal women-a multicenter randomized clinical trial. Menopause 2010, 17(2):269-280.
140. Hunter M.S., Liao K.L. Determinants of treatment choice for menopausal hot flushes: hormonal versus psychological versus no treatment. J Psychosom Obstet Gynaecol 1995, 16(2):101-108.
141. Freedman R.R., Woodward S. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992, 167(2):436-439.
142. Younus J., Simpson I., Collins A., et al. Mind control of menopause. Womens Health Issues 2003, 13(2):74-78.
143. Elkins G., Marcus J., Stearns V., et al. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. J Clin Oncol 2008, 26(31):5022-5026.
144. Duijts S.F., Oldenburg H.S., van Beurden M., et al. Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment-induced menopause: design of a multicenter trial. BMC Womens Health 2009, 9:15.
145. Ivarsson T., Spetz A.C., Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 1998, 29(2):139-146.
146. Mastrangelo M.A., Galantino M.L., House L. Effects of yoga on quality of life and flexibility in menopausal women: a case series. Explore (NY): 2007, 3(1):42-45.
147. Daley A.J., Stokes-Lampard H.J., Macarthur C. Exercise to reduce vasomotor and other menopausal symptoms: a review. Maturitas 2009, 63(3):176-180.